Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q4 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through the Retail Pharmacy and Pharmacy Services segments. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

Rite Aid Corp. said Tuesday it will start charging $115 per COVID-19 test from Dec. 1, following the end of federal funding for diagnostic testing by the U.S. Department of Health and Human Services. The drug store chain said it will offer testing for individuals aged 13 and older regardless of whether they are symptomatic or asymptomatic.

Rite Aid to start charging $115 per COVID-19 test from Dec. 1 as federal funding ends

CAMP HILL, Pa.--(BUSINESS WIRE)--To continue to provide its customers with an essential service during the pandemic, Rite Aid (NYSE: RAD) is updating its COVID-19 testing program following the end of federal funding for diagnostic testing by the U.S. Department of Health and Human Services (HHS). Effective December 1, 2020, no-charge testing at Rite Aid's existing testing sites will be replaced by testing for individuals 13 years of age and older for $115 per test (payable via cash, credit, deb

Rite Aid Updates COVID-19 Testing Program

CAMP HILL, Pa.--(BUSINESS WIRE)--The Rite Aid Foundation is providing grants for $1 million each to Girls on the Run and SeriousFun Children's Network.

Rite Aid Foundation Announces New Partnerships With Girls on the Run, SeriousFun Children's Network

CVS Health

GoodRx Holdings

Walgreens

A few years ago, Amazon was supposed to disrupt the grocery industry. That didn't happen.

1 Big Reason Why Pharmacy Investors Shouldn't Fear Amazon

A formidable competitor is entering the healthcare arena.

Why CVS, Walgreens, Rite Aid, and Other Pharmacy Stocks Plunged Today

The announcement sent shares of CVS tumbling 8.8 percent Tuesday afternoon, while Rite Aid plummeted 16 percent and Walgreens Boots Alliance was down 8.4 percent.

Amazon Pharmacy announcement sends stocks of drugstore chains tumbling

Drugstore stocks, such as CVS, Walgreens, Goodrx Holdings, and Rite Aid are taking a beating on Tuesday following news from Amazon. The post Drugstore Stocks News: Why CVS, WBA, GDRX and RAD Are Sinking Today appeared first on InvestorPlace.

Drugstore Stocks News: Why CVS, WBA, GDRX and RAD Are Sinking Today

Amazon's foray into the prescription-medicine space deepened on Tuesday after the e-commerce giant launched a digital pharmacy store as a section within its retail website. Now, shoppers can buy their prescription medicines directly from Amazon's website, with the ability to pay with insurance or without. Amazon Prime members will receive discounts on certain medicines and two-day shipping, adding a few more perks to the list of Amazon Prime benefits.

Pharmacy stocks are getting Amazon'd as the consumer giant pushes into online prescriptions — and CVS and Walgreens are tanking

CVS, Rite Aid and other pharmacy stocks were under pressure on Tuesday morning after Amazon's newest venture was announced.

Walgreens drops 11% to lead drug store stocks lower after Amazon launches pharmacy business

Kohl's

Walmart

It was once just a catchphrase but more retailers are figuring out ways to cash in on the health and wellness movement driven by Covid and demographics

Walmart, Kohl's And Big Drug Chains Look For Wealth From Health

Rite Aid, locked in a battle for U.S. market share with CVS and Walgreens, unveiled its rebranding Monday (Nov. 9) along with a new vision for its in-store and digital-first experience. “This is an important milestone in our relentless pursuit of becoming the preeminent whole health destination.

Rite Aid Rebrands, Reconfigures Retail Experience

Rite Aid Corp. shares rose 2.8% in Monday premarket trading after the pharmacy retailer announced a new marketing and branding campaign that includes a new corporate logo, digital experience and a test of a "store of the future" design. Rite Aid says it is targeting millennial and Gen X women, and has been working towards the revamp over the last year, with new supplier relationships, employee training and tools and more.

Rite Aid announces rebranding, new store design test

Rite Aid is betting that new stores that put pharmacists at the front instead of the back will help it draw customers at a time when competition from online shopping is surging.

This is the Rite Aid of the future

CAMP HILL, Pa.--(BUSINESS WIRE)--Taking the next step in its transformation, Rite Aid (NYSE: RAD) officially launched its refreshed brand today with an advertising campaign that demonstrates Rite Aid's commitment to provide the perfect fusion of traditional medicine and alternative remedies to help people not just get healthy, but get thriving. The brand refresh also includes a new brand identity (logo) that is rolling out across the chain, whole health merchandise, a refreshed digital experien

Rite Aid Unveils Vision for the Future of Retail Pharmacy

Dropbox

Etsy

II-VI Incorporated

Peloton

ViacomCBS

Yelp

Companies are always seeking growth through mergers and acquisitions, so investors could pick buyout stocks before the market does. The post 7 Stocks That Look Like Great Buyout Targets appeared first on InvestorPlace.

7 Stocks That Look Like Great Buyout Targets

Teva Pharmaceutical

You probably shouldn't invest in these healthcare stocks unless you're betting on a turnaround, and soon.

2 Stocks That Could Go Bankrupt in 2021

Rite Aid and friends could easily be exceptions to that trend. Price action in PBM equities this year is, arguably, pricing in not only a victory by former Vice President Joe Biden, but the Democrats controlling both houses of Congress come January 2021.

Rite Aid Stock Isn’t all that RAD

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) today enhanced its targeted digital media capability through a partnership with the leading digital promotions, media, and analytics company, Quotient, to exclusively connect brands and advertisers to Rite Aid digital customers. At a time when marketers are foregoing traditional channels in favor of more targeted and measurable alternatives, Rite Aid’s customer base represents an important audience with which brands can engage. Through its p

Rite Aid to Launch Rite Aid Performance Media Powered by Quotient

RAD stock seemed like a winner under new management, but the fiscal Q2 report spotlights what's standing in the company's way. The post Q2 Earnings Highlight the Roadblock in Rite Aid’s Turnaround appeared first on InvestorPlace.

Q2 Earnings Highlight the Roadblock in Rite Aid’s Turnaround

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) has appointed Angele Robinson-Gaylord as senior vice president, store development. She is the latest in a series of senior leaders to join Rite Aid with the skill and imagination to help drive forward Rite Aid’s RxEvolution – the company’s business strategy. Robinson-Gaylord will play a key role in executing and managing renovations for Rite Aid’s Stores of the Future – a critical component of RxEvolution that will transform Rite Aid stores

Angele Robinson-Gaylord Named Senior Vice President, Store Development at Rite Aid

Allegiant Travel Company

Aramark

Bitauto Hlds

Vail Resorts

Figuring out bloated toxic stocks on a consistent basis and discarding them at the right time is the key to successful investing.

5 Toxic Stocks That You Should Not be Owning

Rite Aid's (RAD) acquisition deal with Bartell Drugs is likely to strengthen its foothold in mid-market PBM and help boost the RxEvolution strategy.

Rite Aid Ups Game in PBM Space Via Bartell Drugs' Buyout

Rite Aid’s CEO said the company hopes to be “your local neighborhood pharmacy.”

Rite Aid Agrees To Acquire Seattle-Area Bartell Drugs For $95 Million

Rite Aid said it will pay $95 million to buy Bartell Drugs, a family-owned Seattle-based drugstore chain of 67 pharmacies.

Rite Aid To Buy Seattle’s Bartell Drugs Chain

CAMP HILL, Pa. & SEATTLE--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) and Bartell Drugs today announced they have entered into a definitive agreement under which Rite Aid will acquire Bartell Drugs. Founded in 1890, family-owned Bartell Drugs generates over $550 million in revenue and fills approximately 5.5 million prescriptions annually across its 67 stores in Seattle and throughout King, Snohomish and Pierce counties in Washington state. Bartell Drugs’ stores join Rite Aid’s existing 69 Seattle ar

News for Rite Aid Stock (RAD)